Mechanisms of Pannexin Channel Activation and permeation
Mechanisms of Pannexin Channel Activation and permeation
批准号:
10625334
负责人:
Douglas A. Bayliss
金额:
$39.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2024-05-31
关键词:
AddressAdrenergic ReceptorApoptosisBiological AssayBiophysical ProcessBlood PressureBlood VesselsC-terminalCaspaseCellsCoupledDataDisputesDyesFamilyFluorescent DyesG alpha q ProteinG-Protein-Coupled ReceptorsGTP-Binding ProteinsGeneticHDAC6 geneHeterotrimeric GTP-Binding ProteinsIn VitroInflammationInsulin ReceptorInterventionIon ChannelIonsKnock-inLinkMeasuresMediatingMembraneMolecularMutant Strains MiceMutationNucleotidesPathway interactionsPhosphorylationPhosphotransferasesPhysiologicalPhysiologyProcessPropertyProtein-Serine-Threonine KinasesReagentReceptor SignalingRegulationSTK11 geneSignal PathwaySignal TransductionSignaling MoleculeSystemTO-PRO-3TailTestingTherapeuticTimeVascular resistanceWorkYeastsblood glucose regulationmembrane fluxmimeticsnovelpharmacologicproteoliposomesreceptorreconstitutionsalt-inducible kinasesynergismtooluptakeyeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT 4 PROJECT SUMMARY
Pannexin 1 (Panx1) is a widely-expressed membrane ion channel that, when activated, leads to transmembrane
flux of large molecules (i.e., nucleotides, other metabolites) that can mediate intercellular signaling in multiple
(patho)physiological contexts (e.g., see Projects 1-3). Thus, understanding the different cellular and molecular
mechanisms for channel activation, and the determinants for large molecule permeation, are of paramount
importance to reveal novel potential therapeutic strategies for pathway-specific pharmacological intervention that
could selectively modulate permeation of specific signaling metabolites in different contexts.
Among well-established Panx1 activation mechanisms, that mediated by Gαq protein-coupled receptors
(GαqPCRs) is widespread, but the essential cellular, molecular and biophysical mechanisms that mediate this
prevalent form of channel activation have not been elucidated. Our preliminary data implicate the salt-inducible
kinase, SIK1, a serine-threonine kinase that physically associates with Panx1, and is both necessary and
sufficient for channel activation. In Aim 1, supported by additional preliminary observations, we test the
hypothesis that GαqPCRs signal via non-canonical pathways involving LKB1 and RhoA-mDia-HDAC6, which
converge to activate SIK1 to mediate phosphorylation and activation of Panx1. For this, we use genetic and
pharmacological tools, in heterologous and native systems, to determine the relevant signaling pathways and
identify critical channel phosphosites by mutational, mass spectrometric and in vitro kinase approaches. In
addition, we use single channel recordings to characterize properties of partially and fully receptor-activated wild
type and concatenated Panx1 constructs, examining whether channels activate in the novel stepwise fashion
that we recently discovered for C-terminally cleavage-activated channels.
Panx1 channels are renowned for their association with nucleotide release and dye uptake. Nonetheless, it
has not been established whether these large molecules actually permeate via the channel itself, and even the
ionic selectivity of Panx1 has not been established. In addition, channels activated by different mechanisms
display distinct single channel properties, suggesting that they may also yield distinct permeation properties that
support release of specific signaling molecules. In Aim 2, we implement a proteoliposome system incorporating
purified Panx1 to test the hypothesis that activated Panx1 provides a permeation pathway that supports release
of various cellular constituents, and that flux of different molecules is influenced by distinct modes of channel
activation. By directly measuring permeation of specific signaling metabolites through these purified Panx1
channels, we will identify the range of metabolites that can transit the channel when activated by either caspase-
mediated C-terminal cleavage or SIK1-mediated phosphorylation.
This work defines molecular mechanisms underlying physiologically relevant forms of Panx1 regulation, and
identifies permeation properties and signaling metabolites supported by specific activation mechanisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Pannexin Channel Activation and permeation
-
批准号:10407616
-
项目类别:
-
资助金额:$39.79万
-
财政年份:2014
-
负责人:Douglas A. Bayliss
-
依托单位:
Pannexin Channels In Vascular Physiology & Inflammation
-
批准号:10200118
-
项目类别:
-
资助金额:$243.63万
-
财政年份:2014
-
负责人:Douglas A. Bayliss
-
依托单位:
Pannexin Channels In Vascular Physiology & Inflammation
-
批准号:10407608
-
项目类别:
-
资助金额:$243.63万
-
财政年份:2014
-
负责人:Douglas A. Bayliss
-
依托单位:
Mechanisms of Pannexin Channel Activation and permeation
-
批准号:10200125
-
项目类别:
-
资助金额:$39.79万
-
财政年份:2014
-
负责人:Douglas A. Bayliss
-
依托单位:
Pannexin Channels In Vascular Physiology & Inflammation
-
批准号:10625317
-
项目类别:
-
资助金额:$243.63万
-
财政年份:2014
-
负责人:Douglas A. Bayliss
-
依托单位:
Release of find-me signals during apoptotic cell clearance
-
批准号:8730208
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2013
-
负责人:Douglas A. Bayliss
-
依托单位:
Release of find-me signals during apoptotic cell clearance
-
批准号:9066751
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2013
-
负责人:Douglas A. Bayliss
-
依托单位:
Release of find-me signals during apoptotic cell clearance
-
批准号:8562561
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2013
-
负责人:Douglas A. Bayliss
-
依托单位:
Cellular/Molecular Mechanisms of Respiratory Neuronal Chemosensitivity
-
批准号:10321300
-
项目类别:
-
资助金额:$48.45万
-
财政年份:2011
-
负责人:Douglas A. Bayliss
-
依托单位:
Cellular/Molecular Mechanisms of Respiratory Neuronal Chemosensitivity
-
批准号:8461983
-
项目类别:
-
资助金额:$36.65万
-
财政年份:2011
-
负责人:Douglas A. Bayliss
-
依托单位:
Cellular/Molecular Mechanisms of Respiratory Neuronal Chemosensitivity
-
批准号:8658141
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2011
-
负责人:Douglas A. Bayliss
-
依托单位:
Cellular/Molecular Mechanisms of Respiratory Neuronal Chemosensitivity
-
批准号:9276094
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2011
-
负责人:Douglas A. Bayliss
-
依托单位:
Cellular/Molecular Mechanisms of Respiratory Neuronal Chemosensitivity
-
批准号:8259443
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2011
-
负责人:Douglas A. Bayliss
-
依托单位:
Cellular/Molecular Mechanisms of Respiratory Neuronal Chemosensitivity
-
批准号:8131531
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2011
-
负责人:Douglas A. Bayliss
-
依托单位:
Cellular/Molecular Mechanisms of Respiratory Neuronal Chemosensitivity
-
批准号:10548129
-
项目类别:
-
资助金额:$48.45万
-
财政年份:2011
-
负责人:Douglas A. Bayliss
-
依托单位:
Anesthetic Action:Channels Substrates & Mechanisms
-
批准号:6637862
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2002
-
负责人:Douglas A. Bayliss
-
依托单位:
Anesthetic Action: Channel Substrates & Molecular Mechanisms
-
批准号:7095724
-
项目类别:
-
资助金额:$31.65万
-
财政年份:2002
-
负责人:Douglas A. Bayliss
-
依托单位:
Anesthetic Action: Channel Substrates & Molecular Mechanisms
-
批准号:7208068
-
项目类别:
-
资助金额:$30.72万
-
财政年份:2002
-
负责人:Douglas A. Bayliss
-
依托单位:
Anesthetic Action: Channel Substrates & Molecular Mechanisms
-
批准号:7652526
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2002
-
负责人:Douglas A. Bayliss
-
依托单位:
Anesthetic Action: Molecular Substrates & Neural Mechanisms
-
批准号:8302430
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2002
-
负责人:Douglas A. Bayliss
-
依托单位:
海外基金